Breaking Into a Crowded Category: Octeangin OTx Launch in Hungary
Octeangin is a broad-spectrum throat antiseptic manufactured by Germany’s Klosterfrau, combining antibacterial, antifungal and antiviral action through its active ingredient octenidine. When we launched it in Hungary three years ago, we were entering one of the most competitive OTC categories on the market — and we had a single SKU to do it with.
The Challenge
The throat pain category in Hungary is saturated. International heavyweights like Strepsils and Tantum Verde compete across dozens of SKUs, flavours and formats, with significant consumer marketing budgets and years of brand recognition behind them. Launching a new entrant — even a clinically differentiated one — into that environment is a formidable task. Standing out on shelf alone was never going to be the strategy.
What We Did
Field Sales & Key Account Activation
Leveraging our in-house field sales team and key account management capabilities, we rapidly built Octeangin’s pharmacy presence across Hungary.
Pharmacy Reach & Trade Visibility
The product is today available in over 80% of Hungarian pharmacies, with regular visibility in pharmacy trade publications.
Professional Outreach & HCP Recommendation
Through a combination of direct and indirect professional outreach, Octeangin has become a preferred recommendation among GPs and ENT specialists.
Impact
% +
0
80%+ Pharmacy distribution reached within months of launch
annual growth
+
0
+60% Year-on-year growth, sustained consistently since launch
market share
0
~6% Market share reached — with a single SKU, in a multi-player, multi-format category
June 2026 Statistics